US lingerie company Victoria’s Secret has brought a lawsuit over the sale of knockoff products that mimic the get-up of its trade marked body care products, ahead of the much-anticipated launch of its first store in Australia.
Ophthalmic diagnostic device maker ObjectiVision’s amended claims for damages, filed after a 25-day patent hearing, are “outlandish” and “unfair,” the University of Sydney has told the Federal Court.
Supermarket dessert maker Wicked Sister has brought a trade mark infringement suit against the maker of dipping sauces that this year launched a dessert it branded Wicked Waffle Dippers.
The Australian Bar Association can move forward with its plans to trade mark the terms ‘Austbar’ and ‘Aust bar’ after defeating a second challenge brought by a rival barristers group.
A conglomerate of entertainment companies, including Roadshow Films, Columbia Pictures and Disney, have launched further court proceedings against Australia’s telecommunication giants to block 151 domains accused of facilitating the piracy of copyrighted movies and TV shows.
When US food giant Kraft faces off next week in its lawsuit against Aussie cheese company Bega for allegedly violating its peanut butter trade dress, the court will be faced with the thorny task of unraveling a complex corporate transaction that left both companies claiming rights to the iconic trade dress.
US tyre company Goodyear wants to challenge a ruling in a long-running dispute with UK-based rival Dunlop over coveted trade marks for ‘Dunlop’ and ‘Flying D’.
Aristocrat Technologies is pushing on with its bid for four innovation gaming patents, after a delegate for IP Australia revoked the patents because they amounted to nothing more than ‘games and game rules’.
Globe International denies that it violated the law when it sent multiple letters to Kmart allegedly threatening legal action for infringing its copyright for cargo pants and shorts.
Two generic drug makers have lost their bid for confidential documents related to Neurim Pharmaceuticals’ patents covering sleep drug Circadin, with a court ruling legal professional privilege was waived in a phone conversation between a DLA Piper lawyer and the company’s founder.